
Pre-Taxane Lutetium in Prostate Cancer: Changing the Treatment Algorithm
Is there a role for earlier integration of lutetium PSMA therapy in mCRPC management? Emerging evidence supports its use in the pre-taxane setting, prompting a shift in sequencing decisions. This episode outlines patient
























